All In Biotech

Drug Trial Radar · NCT01722942

Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of Death

CHronic Use of Amiodarone aGAinSt Implantable Cardioverter-defibrillator Therapy for Primary Prevention of Death in Patients With Chagas Cardiomyopathy Study (CHAGASICS)

Last checked: Nov 20, 2026Latest source record: Aug 30, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 1,100 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

1,100

Planned (sponsor's estimate)

Start

Oct 6, 2014

Primary completion

Jul 31, 2022

Study completion Jul 31, 2022

Sponsor

Lead sponsor
InCor Heart InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Ministry of Health, Brazil; Abbott Medical Devices
First posted
Nov 7, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective is to compare the efficacy of the treatment using implantable cardioverter defibrillator (ICD) implantation to that of the treatment using amiodarone in the primary prevention of all-cause mortality in high-risk patients with Chagas cardiomyopathy and non-sustained ventricular tachycardia (NSVT).

Conditions

  • Chagas Cardiomyopathy
  • Non-sustained Ventricular Tachycardia
  • At Least 10 Points in Rassi Risk Score for Death

Interventions

  • ICD implantationProcedure

    ventricular ICD implantation

  • amiodarone hydrochlorideDrug

    amiodarone prescription

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. all cause mortalityTime frame: three and half years

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Hospital Universitário Walter Cantideo

    Fortaleza, Ceará, Brazil · Recruiting

  • Hospital Ana Nery

    Salvador, Estado de Bahia, Brazil · Not yet recruiting

  • Instituto de Cardiologia do Distrito Federal

    Brasília, Federal District, Brazil · Recruiting

  • Anis Rassi Hospital

    Goiânia, Goiás, Brazil · Not yet recruiting

  • Hospital das Clínicas de Goiania

    Goiânia, Goiás, Brazil · Recruiting

  • Santa Casa de Goiania

    Goiânia, Goiás, Brazil · Not yet recruiting

  • Hospital Felício Rocho

    Belo Horizonte, Minas Gerais, Brazil · Not yet recruiting

  • Hospital das Clínicas Samuel Libânio

    Pouso Alegre, Minas Gerais, Brazil · Not yet recruiting

  • Hospital Escola da Universidade Federal do Triângulo Mineiro

    Uberaba, Minas Gerais, Brazil · Not yet recruiting

  • Hospital Geral Universitário

    Cuiabá, Mount, Brazil · Not yet recruiting

  • Hospital Santa Casa de Misericórdia de Curitiba

    Curitiba, Paraná, Brazil · Not yet recruiting

  • Hospital Universitário Procape

    Recife, Pernambuco, Brazil · Not yet recruiting

  • Hospital das Clínicas da UNICAMP

    Campinas, São Paulo, Brazil · Not yet recruiting

  • Santa Casa de Ribeirão Preto

    Ribeirão Preto, São Paulo, Brazil · Not yet recruiting

  • HC - FMUSP / Ribeirão Preto

    Ribeirão Preto, São Paulo, Brazil · Recruiting

  • Instituto de Moléstias Cardiovasculares

    São José do Rio Preto, São Paulo, Brazil · Recruiting

  • Heart Institute (InCor) - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

    São Paulo, São Paulo, Brazil · Recruiting

  • Beneficiência Portuguesa

    São Paulo, São Paulo, Brazil · Not yet recruiting

  • Escola Paulista de Medicina

    São Paulo, São Paulo, Brazil · Recruiting

  • Instituto Dante Pazzanese de Cardiologia

    São Paulo, São Paulo, Brazil · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.